New Insight into Isoprenoids Biosynthesis Process and Future Prospects for Drug Designing in Plasmodium
Open Access
- 13 September 2016
- journal article
- review article
- Published by Frontiers Media SA in Frontiers in Microbiology
- Vol. 7, 1421
Abstract
The MEP (Methyl Erythritol Phosphate) isoprenoids biosynthesis pathway is an attractive drug target to combat malaria, due to its uniqueness and indispensability for the parasite. It is functional in the apicoplast of Plasmodium and its products get transported to the cytoplasm, where they participate in glycoprotein synthesis, electron transport chain, tRNA modification and several other biological processes. Several compounds have been tested against the enzymes involved in this pathway and amongst them Fosmidomycin, targeted against IspC (DXP reductoisomerase) enzyme and MMV008138 targeted against IspD enzyme have shown good anti-malarial activity in parasite cultures. Fosmidomycin is now-a-days prescribed clinically, however, less absorption, shorter half-life, and toxicity at higher doses, limits its use as an anti-malarial. The potential of other enzymes of the pathway as candidate drug targets has also been determined. This review details the various drug molecules tested against these targets with special emphasis to Plasmodium. We corroborate that MEP pathway functional within the apicoplast of Plasmodium is a major drug target, especially during erythrocytic stages. However, the major bottlenecks, bioavailability and toxicity of the new molecules needs to be addressed, before considering any new molecule as a potent antimalarial.Keywords
Funding Information
- University Grants Commission (F.2-1/2012(SA-1), 42-182/2013 (SR))
- Council of Scientific and Industrial Research (09/719(0058)/2013)
This publication has 101 references indexed in Scilit:
- Cloning and characterization of bifunctional enzyme farnesyl diphosphate/geranylgeranyl diphosphate synthase from Plasmodium falciparumMalaria Journal, 2013
- Production of recombinant 1‐deoxy‐d‐xylulose‐5‐phosphate synthase from Plasmodium vivax in Escherichia coliFEBS Open Bio, 2013
- Study of IspH, a Key Enzyme in the Methylerythritol Phosphate Pathway Using Fluoro-Substituted Substrate AnaloguesOrganic Letters, 2011
- Identification of novel small molecule inhibitors of 4-diphosphocytidyl-2-C-methyl-d-erythritol (CDP-ME) kinase of Gram-negative bacteriaBioorganic & Medicinal Chemistry, 2011
- Molecular basis of fosmidomycin's action on the human malaria parasite Plasmodium falciparumScientific Reports, 2011
- Pyridine Inhibitor Binding to the 4Fe-4S Protein A. aeolicus IspH (LytB): A HYSCORE InvestigationJournal of the American Chemical Society, 2011
- Organometallic mechanism of action and inhibition of the 4Fe-4S isoprenoid biosynthesis protein GcpE (IspG)Proceedings of the National Academy of Sciences, 2010
- Probing the reaction mechanism of IspH protein by x-ray structure analysisProceedings of the National Academy of Sciences, 2009
- Structure of (E)-4-Hydroxy-3-methyl-but-2-enyl Diphosphate Reductase, the Terminal Enzyme of the Non-Mevalonate PathwayJournal of the American Chemical Society, 2008
- Membrane transporters in the relict plastid of malaria parasitesProceedings of the National Academy of Sciences, 2006